Asia passed the grim milestone of 1 million coronavirus-linked deaths on March 11, a Reuters tally showed, as a spike in Omicron variant infections spreads across the region after starting in nations such as Japan and South Korea.
Researchers in Singapore developed the world’s largest and highest-resolution atlas of gastric cancer.
With a new wave of Covid-19 infections fueled by the Delta variant striking countries worldwide, disease experts are scrambling to learn whether the latest version of coronavirus is making people – mainly the unvaccinated – sicker than before.
The help wanted signs are up across the biopharma industry. According to BioSpace, companies are opening and expanding facilities, which is good news for job seekers.
Building on the success of the company’s mRNA research, BioNTech will establish its first regional hub in the Asia Pacific region. The company will open a state-of-the-art manufacturing facility to support a global supply of mRNA-based vaccines and therapeutics in Singapore.
Confidence in Covid-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on March 5.
China’s Sinovac Biotech defended the safety and efficacy of the company’s experimental Covid-19 vaccine, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.
The global tally of confirmed coronavirus cases hit 60 million on Nov. 25, with the pace of new infections accelerating and the United States reporting record numbers of hospitalizations, according to a Reuters tally.
A key modeling study from Singapore has found that putting multiple social lockdowns in place – including school closures – will have the biggest impact on curbing COVID-19, the pandemic disease caused by the new coronavirus.
Fitbit Inc. won a contract with the Singapore government to provide fitness trackers and services to up to one million of the country’s citizens as part of a health initiative that begins in October 2019.